10-Q/A XBRL

AMENDMENT NO. 1 TO FORM 10-Q

Company: ADIAL PHARMACEUTICALS, INC.
Filed: October 30, 2023
Period of Report: June 30, 2023
Accession Number: 0001213900-23-081597

View Document ↗ View on SEC.gov ↗